These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

762 related items for PubMed ID: 9202001

  • 1. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells.
    Franklin CC, Kraft AS.
    J Biol Chem; 1997 Jul 04; 272(27):16917-23. PubMed ID: 9202001
    [Abstract] [Full Text] [Related]

  • 2. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
    Franklin CC, Kraft AS.
    Oncogene; 1995 Dec 07; 11(11):2365-74. PubMed ID: 8570188
    [Abstract] [Full Text] [Related]

  • 3. Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis.
    Franklin CC, Srikanth S, Kraft AS.
    Proc Natl Acad Sci U S A; 1998 Mar 17; 95(6):3014-9. PubMed ID: 9501207
    [Abstract] [Full Text] [Related]

  • 4. Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity.
    Laderoute KR, Mendonca HL, Calaoagan JM, Knapp AM, Giaccia AJ, Stork PJ.
    J Biol Chem; 1999 Apr 30; 274(18):12890-7. PubMed ID: 10212278
    [Abstract] [Full Text] [Related]

  • 5. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation.
    Chu Y, Solski PA, Khosravi-Far R, Der CJ, Kelly K.
    J Biol Chem; 1996 Mar 15; 271(11):6497-501. PubMed ID: 8626452
    [Abstract] [Full Text] [Related]

  • 6. Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways.
    Li C, Hu Y, Mayr M, Xu Q.
    J Biol Chem; 1999 Sep 03; 274(36):25273-80. PubMed ID: 10464250
    [Abstract] [Full Text] [Related]

  • 7. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
    Wadgaonkar R, Pierce JW, Somnay K, Damico RL, Crow MT, Collins T, Garcia JG.
    Am J Respir Cell Mol Biol; 2004 Oct 03; 31(4):423-31. PubMed ID: 15231489
    [Abstract] [Full Text] [Related]

  • 8. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
    Slack DN, Seternes OM, Gabrielsen M, Keyse SM.
    J Biol Chem; 2001 May 11; 276(19):16491-500. PubMed ID: 11278799
    [Abstract] [Full Text] [Related]

  • 9. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
    Wu W, Pew T, Zou M, Pang D, Conzen SD.
    J Biol Chem; 2005 Feb 11; 280(6):4117-24. PubMed ID: 15590693
    [Abstract] [Full Text] [Related]

  • 10. Activation of the mitogen-activated protein kinase pathway in U937 leukemic cells induces phosphorylation of the amino terminus of the TATA-binding protein.
    Biggs JR, Ahn NG, Kraft AS.
    Cell Growth Differ; 1998 Aug 11; 9(8):667-76. PubMed ID: 9716183
    [Abstract] [Full Text] [Related]

  • 11. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
    Reffas S, Schlegel W.
    Biochem J; 2000 Dec 15; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
    [Abstract] [Full Text] [Related]

  • 12. Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5.
    Tanoue T, Moriguchi T, Nishida E.
    J Biol Chem; 1999 Jul 09; 274(28):19949-56. PubMed ID: 10391943
    [Abstract] [Full Text] [Related]

  • 13. Hyperosmotic induction of the mitogen-activated protein kinase phosphatase MKP-1 in H4IIE rat hepatoma cells.
    Schliess F, Heinrich S, Häussinger D.
    Arch Biochem Biophys; 1998 Mar 01; 351(1):35-40. PubMed ID: 9500841
    [Abstract] [Full Text] [Related]

  • 14. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation.
    Liu Y, Gorospe M, Yang C, Holbrook NJ.
    J Biol Chem; 1995 Apr 14; 270(15):8377-80. PubMed ID: 7721728
    [Abstract] [Full Text] [Related]

  • 15. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
    Hutter D, Chen P, Barnes J, Liu Y.
    Biochem J; 2000 Nov 15; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of mitogen-activated protein kinase inhibition by parathyroid hormone in osteoblast-like cells.
    Hömme M, Schmitt CP, Mehls O, Schaefer F.
    J Am Soc Nephrol; 2004 Nov 15; 15(11):2844-50. PubMed ID: 15504937
    [Abstract] [Full Text] [Related]

  • 17. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases.
    Muda M, Theodosiou A, Rodrigues N, Boschert U, Camps M, Gillieron C, Davies K, Ashworth A, Arkinstall S.
    J Biol Chem; 1996 Nov 01; 271(44):27205-8. PubMed ID: 8910287
    [Abstract] [Full Text] [Related]

  • 18. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase.
    Camps M, Nichols A, Gillieron C, Antonsson B, Muda M, Chabert C, Boschert U, Arkinstall S.
    Science; 1998 May 22; 280(5367):1262-5. PubMed ID: 9596579
    [Abstract] [Full Text] [Related]

  • 19. Regulation of mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle cells.
    Bokemeyer D, Lindemann M, Kramer HJ.
    Hypertension; 1998 Oct 22; 32(4):661-7. PubMed ID: 9774360
    [Abstract] [Full Text] [Related]

  • 20. High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation.
    Begum N, Ragolia L.
    Am J Physiol Cell Physiol; 2000 Jan 22; 278(1):C81-91. PubMed ID: 10644515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.